Skip to main content
Grant Details

Grant Number: 5R01CA216265-03 Interpret this number
Primary Investigator: Christensen, Brock
Organization: Dartmouth College
Project Title: (PQ3) Immune Epigenetic Biomarkers of Bladder Cancer Outcomes
Fiscal Year: 2019
Back to top


ABSTRACT There are an estimated 765,000 people with a diagnosis of bladder cancer living in the United States and risk of disease recurrence and progression can be high. Frequent, invasive transurethral screening procedures to monitor for recurrence and progression burden both patients and the health care system. A better understanding of the tumor-associated immune responses in bladder cancer patients could provide for more informed clinical decisions on the necessary frequency of invasive follow up procedures and reduce patient morbidity. We propose to leverage an existing population-based study of bladder cancer that includes a range of patient age groups, has several years of follow up, includes patient treatment and outcome data, as well as matched tumor samples. Our collaborative group has developed and extensively validated epigenetic biomarkers of leukocyte subtypes allowing the use of archival DNA to study immune profiles. Here we will use our proven framework to expand our repertoire of leukocyte epigenetic biomarkers to include myeloid derived suppressor cells (MDSC), and test and validate the relation of MDSC and other leukocyte subtypes (including the neutrophil to lymphocyte ratio: NLR), and cell type activation states with bladder cancer outcomes; recurrence, progression, and survival. We will use time-to-event analysis and aim to understand the independent contributions of immune profiles, age at diagnosis, tumor stage and grade, smoking history, and treatment (including BCG immunotherapy), with bladder cancer outcomes. In addition, we propose to measure somatic alteration profiles of bladder tumors from matched subjects and assess the relation of blood immune signatures with tumor methylation and survival to understand the crosstalk between tumor profiles and patient immune responses. Finally, in an exploratory aim we will prospectively investigate both pre-treatment and post- treatment immune signatures in bladder cancer patients. At this opportune time of emerging immunomodulatory therapeutics our existing population-based study resource provides a cost-efficient setting to advance towards improved risk projection in newly diagnosed patients by ushering in a novel and flexible immune monitoring toolkit that can inform clinical decision-making using data on tumor-associated immune responses.

Back to top


PyMethylProcess - convenient high-throughput preprocessing workflow for DNA methylation data.
Authors: Levy J.J. , Titus A.J. , Salas L.A. , Christensen B.C. .
Source: Bioinformatics (Oxford, England), 2019-08-01; , .
EPub date: 2019-08-01.
PMID: 31368477
Related Citations

Absence of an embryonic stem cell DNA methylation signature in human cancer.
Authors: Zhang Z. , Wiencke J.K. , Koestler D.C. , Salas L.A. , Christensen B.C. , Kelsey K.T. .
Source: BMC cancer, 2019-07-19; 19(1), p. 711.
EPub date: 2019-07-19.
PMID: 31324166
Related Citations

DNA Methylation Changes in Regional Lung Macrophages Are Associated with Metabolic Differences.
Authors: Armstrong D.A. , Chen Y. , Dessaint J.A. , Aridgides D.S. , Channon J.Y. , Mellinger D.L. , Christensen B.C. , Ashare A. .
Source: ImmunoHorizons, 2019-07-02; 3(7), p. 274-281.
EPub date: 2019-07-02.
PMID: 31356157
Related Citations

Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Authors: Chen Y. , Wang Y. , Salas L.A. , Miller T.W. , Mark K. , Marotti J.D. , Kettenbach A.N. , Cheng C. , Christensen B.C. .
Source: Breast cancer research : BCR, 2019-01-25; 21(1), p. 14.
EPub date: 2019-01-25.
PMID: 30683142
Related Citations

Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis.
Authors: Chen Y. , Armstrong D.A. , Salas L.A. , Hazlett H.F. , Nymon A.B. , Dessaint J.A. , Aridgides D.S. , Mellinger D.L. , Liu X. , Christensen B.C. , et al. .
Source: Clinical epigenetics, 2018-12-10; 10(1), p. 152.
EPub date: 2018-12-10.
PMID: 30526669
Related Citations

Tracing human stem cell lineage during development using DNA methylation.
Authors: Salas L.A. , Wiencke J.K. , Koestler D.C. , Zhang Z. , Christensen B.C. , Kelsey K.T. .
Source: Genome research, 2018 09; 28(9), p. 1285-1295.
EPub date: 2018-08-02.
PMID: 30072366
Related Citations

MicroRNA-Related Genetic Variants Associated with Survival of Head and Neck Squamous Cell Carcinoma.
Authors: Wilkins O.M. , Titus A.J. , Salas L.A. , Gui J. , Eliot M. , Butler R.A. , Sturgis E.M. , Li G. , Kelsey K.T. , Christensen B.C. .
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019 Jan; 28(1), p. 127-136.
EPub date: 2018-06-07.
PMID: 29880533
Related Citations

An optimized library for reference-based deconvolution of whole-blood biospecimens assayed using the Illumina HumanMethylationEPIC BeadArray.
Authors: Salas L.A. , Koestler D.C. , Butler R.A. , Hansen H.M. , Wiencke J.K. , Kelsey K.T. , Christensen B.C. .
Source: Genome biology, 2018-05-29; 19(1), p. 64.
EPub date: 2018-05-29.
PMID: 29843789
Related Citations

Back to Top